These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 32557398

  • 1. Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
    Motta I, Bou-Fakhredin R, Taher AT, Cappellini MD.
    Drugs; 2020 Jul; 80(11):1053-1063. PubMed ID: 32557398
    [Abstract] [Full Text] [Related]

  • 2. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD, Motta I.
    Hematology Am Soc Hematol Educ Program; 2017 Dec 08; 2017(1):278-283. PubMed ID: 29222267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Overview of new approaches to β-thalassemia treatment].
    Guo XF, Han L, Zhang XC, Zhang HH, Liu J.
    Sheng Li Xue Bao; 2024 Jun 25; 76(3):496-506. PubMed ID: 38939943
    [Abstract] [Full Text] [Related]

  • 5. Beta Thalassemia: Monitoring and New Treatment Approaches.
    Khandros E, Kwiatkowski JL.
    Hematol Oncol Clin North Am; 2019 Jun 25; 33(3):339-353. PubMed ID: 31030806
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emerging Therapies in β-Thalassemia.
    Bou-Fakhredin R, Kuo KHM, Taher AT.
    Hematol Oncol Clin North Am; 2023 Apr 25; 37(2):449-462. PubMed ID: 36907614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation.
    Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M.
    Br J Clin Pharmacol; 2022 Aug 25; 88(8):3610-3626. PubMed ID: 35373382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron overload: The achilles heel of β-thalassemia.
    Vlachaki E, Venou TM.
    Transfus Clin Biol; 2024 Aug 25; 31(3):167-173. PubMed ID: 38849068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
    Shash H.
    Medicina (Kaunas); 2022 Oct 21; 58(10):. PubMed ID: 36295656
    [Abstract] [Full Text] [Related]

  • 16. [Current management of thalassemia intermedia].
    Thuret I.
    Transfus Clin Biol; 2014 Nov 21; 21(4-5):143-9. PubMed ID: 25282488
    [Abstract] [Full Text] [Related]

  • 17. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J.
    Int J Hematol; 2018 Jul 21; 108(1):5-21. PubMed ID: 29380178
    [Abstract] [Full Text] [Related]

  • 18. Increasing prevalence of thalassemia in America: Implications for primary care.
    Sayani FA, Kwiatkowski JL.
    Ann Med; 2015 Jul 21; 47(7):592-604. PubMed ID: 26541064
    [Abstract] [Full Text] [Related]

  • 19. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM, Cappellini MD, Taher AT.
    Curr Opin Hematol; 2013 May 21; 20(3):187-92. PubMed ID: 23426199
    [Abstract] [Full Text] [Related]

  • 20. Thalassemia.
    Aydinok Y.
    Hematology; 2012 Apr 21; 17 Suppl 1():S28-31. PubMed ID: 22507773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.